Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(carboethoxyphenyl)retinamide
2. 4-(ethoxycarbophenyl)retinamide
3. N-(4-ethoxycarbophenyl)retinamide
4. Retinamide Ethyl Benzoate
1. 53839-71-7
2. Ethyl 4-(3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamido)benzoate
3. 4-(carboethoxyphenyl)retinamide
4. N-(4-(ethoxycarbonyl)phenyl)retinamide
5. Ethyl 4-[[(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoate
6. Ue38ree8gq
7. Retinamide, N-(4-(ethoxycarbonyl)phenyl)-
8. Retinamide, N-[4-(ethoxycarbonyl)phenyl]-
9. 4-(ethoxycarbophenyl)retinamide
10. Retinamide Ethyl Benzoate
11. Brn 2916567
12. N-(4-ethoxycarbophenyl)retinamide
13. Unii-ue38ree8gq
14. Schembl7159291
15. Dtxsid301318689
16. Mfcd01684778
17. Zinc21985881
18. Akos015894826
19. Ac-15391
20. As-13271
21. 4-(carboethoxyphenyl)retinamide [who-dd]
22. 839v717
23. 2699657-53-7
24. Ethyl 4-(((2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoyl)amino)benzoate
25. Ethyl 4-((2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenamido)benzoate
26. Ethyl4-(3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamido)benzoate
Molecular Weight | 447.6 g/mol |
---|---|
Molecular Formula | C29H37NO3 |
XLogP3 | 7.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 9 |
Exact Mass | 447.27734404 g/mol |
Monoisotopic Mass | 447.27734404 g/mol |
Topological Polar Surface Area | 55.4 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 846 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 4 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Viaminate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Viaminate, including repackagers and relabelers. The FDA regulates Viaminate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Viaminate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Viaminate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Viaminate supplier is an individual or a company that provides Viaminate active pharmaceutical ingredient (API) or Viaminate finished formulations upon request. The Viaminate suppliers may include Viaminate API manufacturers, exporters, distributors and traders.
click here to find a list of Viaminate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Viaminate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Viaminate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Viaminate GMP manufacturer or Viaminate GMP API supplier for your needs.
A Viaminate CoA (Certificate of Analysis) is a formal document that attests to Viaminate's compliance with Viaminate specifications and serves as a tool for batch-level quality control.
Viaminate CoA mostly includes findings from lab analyses of a specific batch. For each Viaminate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Viaminate may be tested according to a variety of international standards, such as European Pharmacopoeia (Viaminate EP), Viaminate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Viaminate USP).
LOOKING FOR A SUPPLIER?